Companies:64525
FatCapitalist:Apple Inc. [AAPL]United States

Evolent Health, Inc. [EVHUnited States

NYSE exchange. Sector: Healthcare. Industry: Health Information Services. Location United States, Arlington.
At close Fri Sep 30 2022
35.93 USD 👍0.69 (+1.92%)

At close Fri Sep 30 2022

Marketcap
3,212,519,168 USD

Marketcap

PE:.
BETA (5y):1.899
EPS:-3.936
Profits

for 5 years

93%

for 3 years

98%

for 2 years

248%

for 1 year

105%

for this year

48%
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.

Evolent partners with payers and providers to dramatically reduce the total cost of care, improve clinical quality and simplify administration.

Evolent Health, Inc.
© 2022 avazzy.com. All rights reserved
Make with 🤎 and ☕ for you!

Investing involves risk, including possible loss of principal.

The strategies discussed are strictly for illustrative and educational purposes and are not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. There is no guarantee that any strategies discussed will be effective.

International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation and the possibility of substantial volatility due to adverse political, economic or other developments. These risks often are heightened for investments in emerging/ developing markets or in concentrations of single countries.